DIG
QNRX

Dauntless Investment Group’s Quoin Pharmaceuticals QNRX Stock Holding History

Dauntless Investment Group’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.3M Buy
+196,592
New +$1.78M 0.86% 17

Other funds holding QNRX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Dauntless Investment Group's QNRX Position: Q1 2026 in Review

Dauntless Investment Group opened a new position in Quoin Pharmaceuticals (QNRX) in Q1 2026: 196,592 shares worth $1.3M. The stake represents 0.86% of the portfolio and ranks #17 among its holdings.

22 funds tracked by Wall St. Rank hold QNRX as of Q1 2026.

  • Dauntless Investment Group held 196,592 shares of Quoin Pharmaceuticals worth $1.3M as of Q1 2026.
  • Quoin Pharmaceuticals was a new Dauntless Investment Group position in Q1 2026.
  • Quoin Pharmaceuticals made up 0.86% of Dauntless Investment Group's portfolio in Q1 2026, its #17 holding.
  • 22 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q1 2026.

Based on Dauntless Investment Group's 13F filing for Q1 2026, filed 14 May 2026.